Senior Vice President, Manufacturing and Bioservices · Emergent BioSolutions Inc. (EBS)

William Hartzel

FY2024 is the first fiscal year CompBrief holds for William Hartzel as a named executive officer of Emergent BioSolutions; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,714,261

Salary $466,970Stock awards $139,500Bonus $585,000

4th of 7 named executive officers at Emergent BioSolutions by FY2024 total.

7 named officers on file for Emergent BioSolutions, FY2024

William Hartzel’s pay file — $29

  • 1 fiscal year of pay, line by line
  • EBS’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Emergent BioSolutions’s whole pay program stands against its peers

  • Emergent BioSolutions’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on EBS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 21, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get William Hartzel’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

William Hartzel compensation by year

Emergent BioSolutions Summary Compensation Table · the one fiscal year held
In US dollars, as Emergent BioSolutions reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$466,970
Bonus$585,000
Stock awards$139,500
Option awards$187,175
Non-equity incentive$325,266
Pension and deferred compensation$0
All other$10,350
Total$1,714,261

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Emergent BioSolutions Inc. DEF 14A filed March 21, 2025, accession 0001367644-25-000080, and prior-year filings.

How this page was built: the Emergent BioSolutions Inc. filed document, accession 0001367644-25-000080. Every figure is read from that document and cited to the page and table it appears in. Filed March 21, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU15,000$143,400—
RSU8,205$78,440—
RSU6,154$58,832—
RSU3,074$29,387—
RSU2,222$21,242—
RSU2,051$19,608—
RSU1,971$18,843—
RSU1,539$14,713—
RSU1,538$14,703—
Option8,209—$8.39
Option2,052—$11.66
Option125,000—$2.33

Per the Outstanding Equity Awards at Fiscal Year-End table in Emergent BioSolutions Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 13 award rows shown.

Insider transactions since the last proxy

11 Form 4 lines since the FY2024 proxy (filed March 21, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-08Tax withholding—1,741$8.00185,558
2026-04-29Grant or award—100,111$0.00187,299
2026-03-05Tax withholding—9,493$8.4487,188
2026-03-03Grant or award derivative—44,834$0.00259,545
2026-02-06Disposition to the issuer—5,771$10.9297,311
2026-02-06Tax withholding—630$10.9296,681
2025-11-11Tax withholding—610$10.88103,082
2025-07-11Tax withholding—4,263$7.36103,692

The 8 most recent of 11 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Emergent BioSolutions’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Joseph PapaPresident, Chief Executive Officer and Director$5,862,562
Richard LindahlExecutive Vice President, Chief Financial Officer$2,311,320
Coleen GlessnerExecutive Vice President, Quality and Ethics and Compliance$2,053,213
William Hartzel · this pageSenior Vice President, Manufacturing and Bioservices$1,714,261
Paul WilliamsSenior Vice President, Products Business$1,675,687
Jennifer FoxFormer Executive Vice President, External Affairs, General Counsel and Corporate Secretary$1,189,933
Haywood MillerFormer Interim Chief Executive Officer$218,750

The full Emergent BioSolutions compensation record

free company brief

This page is one person within Emergent BioSolutions's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Emergent BioSolutions proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Emergent BioSolutions's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

William Hartzel's compensation dossier · One-time report. No refunds.